“Warfarin versus DOACs in the prevention of thromboembolic stroke in patients with Afib. : Warfarin versus DOACs in the prevention of thromboembolic stroke in patients with Afib. ”, JCANPA, vol. 3, no. 7, pp. p1–9, Jun. 2021, doi: 10.5203/jcanpa.v3i7.900.